Reply to: Association Between Alendronate and All-Cause Mortality and Cardiovascular Mortality Among Hip Fracture: An Alternative Explanation

J Bone Miner Res. 2018 Oct;33(10):1908-1909. doi: 10.1002/jbmr.3568. Epub 2018 Sep 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alendronate
  • Bone Density Conservation Agents*
  • Cardiovascular Diseases*
  • Hip Fractures*
  • Humans

Substances

  • Bone Density Conservation Agents
  • Alendronate